{
    "2021-10-17": [
        [
            {
                "time": "",
                "original_text": "华大基因接受13家机构调研！短期主力资金净流出，或存在资金分歧",
                "features": {
                    "keywords": [
                        "华大基因",
                        "机构调研",
                        "主力资金净流出",
                        "资金分歧"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "华大基因：安信证券、财通资管等14家机构于10月15日调研我司",
                "features": {
                    "keywords": [
                        "华大基因",
                        "安信证券",
                        "财通资管",
                        "机构调研"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "华大基因预计前三季度营收超50亿元",
                "features": {
                    "keywords": [
                        "华大基因",
                        "前三季度",
                        "营收",
                        "50亿元"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "解析 | 械企三季度利润公布：华大基因、迪安诊断、达安基因",
                "features": {
                    "keywords": [
                        "华大基因",
                        "迪安诊断",
                        "达安基因",
                        "三季度利润"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技",
                        "医疗器械"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}